miR-22 was originally identified as a tumor suppressor miRNA in many cancers.[19] Lin et al[20] demonstrated that miR-22 is downregulated in the synovial tissue of RA patients and negatively regulates Cyr61 expression, therefore inhibiting RA FLS proliferation and IL-6 production. This evidence concerns the gene CCN1 and cancer.